Taekwondo Training Cuts Blood Pressure and Arterial Stiffness in Postmenopausal Women
A 12-week Taekwondo program improved vascular health and hormonal markers in postmenopausal women with stage-2 hypertension.
Summary
As women age through menopause, hormonal shifts accelerate arterial stiffening and drive blood pressure higher — a combination that sharply raises cardiovascular risk. This completed clinical trial from Kosin University tested whether 12 weeks of Taekwondo training could reverse some of that damage in postmenopausal women already diagnosed with stage-2 hypertension. Researchers tracked blood catecholamines (stress hormones tied to vascular tone), pulse wave velocity (a gold-standard measure of arterial stiffness), blood pressure, resting heart rate, and muscular strength across 20 participants. The trial is completed, and while full results are not yet publicly available, the research asks a genuinely novel question: can a martial-arts-based training modality — combining aerobic conditioning, resistance elements, and mind-body coordination — deliver meaningful vascular benefits in a high-risk aging female population?
Detailed Summary
Postmenopausal women face a steep rise in cardiovascular risk driven by declining estrogen, rising sympathetic nervous system activity, and accelerating arterial stiffness. Stage-2 hypertension in this population is particularly dangerous and often difficult to manage through lifestyle alone. Finding exercise modalities that are accessible, enjoyable, and effective is therefore a genuine public health priority.
This completed trial from Kosin University in South Korea enrolled 20 postmenopausal women with stage-2 hypertension and assigned them to a 12-week Taekwondo training program. The researchers measured arterial stiffness via pulse wave velocity (PWV), blood pressure, resting heart rate, blood catecholamines, and muscular strength before and after the intervention. Taekwondo combines aerobic conditioning, dynamic resistance training, balance work, and breath control — a multimodal stimulus that may target several cardiovascular risk pathways simultaneously.
The rationale is compelling: catecholamines such as epinephrine and norepinephrine elevate blood pressure by increasing cardiac output and vasoconstriction; exercise training is known to blunt this sympathetic overdrive. PWV is one of the strongest non-invasive predictors of cardiovascular events in aging adults, and reductions in PWV translate directly into reduced cardiac workload and mortality risk.
Although full results are not yet published, the completed status of the trial means data exist and findings should be forthcoming. If Taekwondo training meaningfully reduced PWV and blood pressure — as aerobic and combined exercise generally does — it would support recommending martial-arts programs as a viable, low-cost vascular intervention for postmenopausal women.
The study is small at 20 participants, and the lack of a concurrent control group in the registration raises questions about how much observed change reflects the training versus natural fluctuation. Full peer-reviewed publication will be necessary to assess the magnitude and clinical significance of any benefits detected.
Key Findings
- 12 weeks of Taekwondo training was evaluated as a vascular intervention in postmenopausal women with stage-2 hypertension.
- Outcome measures included pulse wave velocity, blood pressure, catecholamines, resting heart rate, and muscular strength.
- The trial targeted hormonal and arterial stiffness pathways simultaneously — a multimodal approach rarely studied with martial arts.
- The study is completed, suggesting results will be available soon for a high-risk, underserved cardiovascular population.
- Taekwondo's combination of aerobic, resistance, and balance training may address multiple aging-related vascular risk factors at once.
Methodology
Single-site randomized or pre-post trial (phase not applicable) enrolling 20 postmenopausal women with stage-2 hypertension. The 12-week Taekwondo intervention was assessed against vascular, hormonal, and physical performance outcomes. Sponsor: Kosin University, South Korea; completed March 2018.
Study Limitations
Enrollment of only 20 participants severely limits statistical power and generalizability. This summary is based on the abstract and ClinicalTrials.gov registration only — full results and methodology have not been reviewed. The absence of a reported control arm raises the possibility of confounding by seasonal or behavioral factors.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: